Hamzeh Abdul Hadi

Senior Principal

Hamzeh Abdul Hadi is a digital health investor based in Dubai and senior principal at Angelini Ventures, the venture arm of the Italian group Angelini. He has invested in digital health for over a decade, previously as investment director at Debiopharm Innovation Fund, the corporate venture arm of the Swiss company Debiopharm International, and before that for six years at Hikma Ventures, where he took part in closing 17 global digital health deals. He has served as board observer at Lemonaid Health, Click Therapeutics, WinterLight Labs and SeamlessMD, and as a board member at Genialis, Fosanis, Altis Labs and Whitelab Genomics. He holds a bachelor's degree in business administration with a finance major from George Washington University, and organised TEDxDeadSea in Jordan.